100%
Clinical AI / Decision Support 4D MapA. Clinical Problem & Target DefinitionA. Clinical Problem & Target Definition
B. Data Strategy & InfrastructureB. Data Strategy & Infrastructure
C. Model Development & EngineeringC. Model Development & Engineering
D. Preclinical & Clinical EvaluationD. Preclinical & Clinical Evaluation
E. Regulatory Strategy & SubmissionE. Regulatory Strategy & Submission
F. Clinical Integration & DeploymentF. Clinical Integration & Deployment
G. Post-Market Surveillance & Lifecycle MgmtG. Post-Market Surveillance & Lifecycle Mgmt
H. Reimbursement, Adoption & EcosystemH. Reimbursement, Adoption & Ecosystem
ALWAYS DEVICE PATHWAY - NO CDS EXEMPTIONUnmet clinical needidentificationClinical workflowanalysis📌 Intended usedefinitionIndications foruse scopingPatient populationspecificationLiterature &evidence reviewExisting AI/CDSlandscape scanClinical championidentificationStakeholder engagement(clinicians, patients, IT)Health systemleadership buy-inMultidisciplinaryteam assemblyInitial ethics reviewIRB determination(exempt vs. full)FeasibilityassessmentBuild vs. buy vs.adapt decisionClinical endpointselectionHealth equityimpact assessmentUse caseprioritizationDICOM imaging dataexport from PACSHL7/FHIR structureddata from EHRClaims & registrydata acquisitionWaveform/signal data(ECG, EEG, CGM)Genomic/multi-omicdata ingestionUnstructured notesextraction (NLP)📌 Data use agreement(DUA) executionHIPAA compliance &privacy reviewDe-identification &privacy engineeringSafe harbor vs. expertdeterminationCohort definition &selection criteriaAnnotation workflowdesignGround truthestablishmentInter-rater reliabilitymeasurement (kappa)Train / validation /test split strategyData representativeness& bias auditMulti-site datacollection logistics📌 Datasheets forDatasets documentationData pipelineinfrastructure (ETL)Data versioning &lineage trackingInformed consent(where applicable)Synthetic datagenerationData governancecommittee reviewAlgorithm architectureselectionCNN / vision model(imaging AI)Transformer / LLM(clinical text)Gradient-boosted trees(tabular EHR)Signal processingmodel (waveforms)Feature engineering& selectionTraining &hyperparameter tuningInternal validation(hold-out set)K-foldcross-validationCalibration assessment(Brier score)Explainability methods(SHAP, Grad-CAM)UncertaintyquantificationSubgroup performanceanalysis (demographics)📌 IEC 62304 softwarelifecycle documentationSoftware architecture& design docsVersion control &reproducibility (MLOps)🏁 GMLP alignmentself-assessment📌 Model Card creation(FDA format)Unit & integrationtestingSoftware bill ofmaterials (SBOM)Foundation modelfine-tuningExternal validation(independent sites)Temporal validation(train past, test future)Silent/shadowprospective deploymentMRMC reader studydesign (imaging AI)Standaloneperformance testingAssistive (human+AI)performance testingAutonomousperformance testingEnriched vs. prevalencestudy designGround truthadjudication processFairness & healthequity auditRobustness & stresstesting (domain shift)Adversarial inputtestingCybersecuritythreat modelingUsability & humanfactors (IEC 62366)Clinical studyprotocol designSample size &power analysisComparator armselectionFormal clinicaltrial needed?📌 ISO 14971risk analysisEdge case & failuremode analysisSite-specificcalibration testingIs this Software as aMedical Device (SaMD)?CDS Criterion 1:NOT image/signal analysisIMAGE / SIGNAL AIALWAYS FAILS CRITERION 1Ultrasound, CT, MRI, X-ray,pathology, retinal, dermoscopy,ECG, EEG, CGM, continuous signalsCDS Criterion 2: Displays/analyzes medical informationCDS Criterion 3:Recommendation to HCPSingle recommendation:enforcement discretion only (2026)Risk scores: enforcementdiscretion (non-acute only)Time-critical predictions:EXCLUDED from discretionCDS Criterion 4: HCP canreview basis independently🏁 All 4 criteria met:Non-Device CDS (exempt)Enforcement discretionzone (2026 guidance)📌 DEVICE PATHWAYENTRYIMDRF SaMD riskcategorization (I-IV)Risk classification:Class I / II / IIIPredicate deviceidentification📌 510(k) pathway(with predicate)📌 De Novo pathway(no predicate, low-mod)📌 PMA pathway(Class III, high risk)Breakthrough Devicedesignation requestPre-Submission meetingrequest (Q-Sub)Pre-Sub interaction& FDA feedbackDevice description& architectureIntended use &indications for useData managementplan documentationModel description& training detailsPerformance validationdata packageHuman factorsdata packageCybersecuritydocumentationLabeling &Model Card📌 PCCP: Descriptionof Modifications📌 PCCP: ModificationProtocol📌 PCCP: ImpactAssessmentFDA substantivereviewAdditional information(AI) requestAdvisory panel review(if applicable)📌 Clearance / Authorization/ ApprovalNot SubstantiallyEquivalent / DenialQMSR 21 CFR 820quality system (ISO 13485)General Wellness pathway(non-invasive wearables)EHR integration(FHIR APIs for CDS)PACS/DICOM integration(imaging AI)LIS integration(laboratory AI)Legacy HL7 v2interface developmentAPI design &interoperability testingIT security review &infrastructure provisioningClinical workflowredesign & embeddingAlert & notificationdesign (CDS)Results displaydesign (imaging AI)Clinician & stafftraining programPilot siteselection criteriaInstitutional AI governancecommittee reviewGo / No-GodecisionSmall-scale pilotdeploymentProspective impactassessment (pilot)Clinician feedbackcollection & iterationWorkflow adjustmentbased on real use📌 ONC HTI-1 FAVEScriteria complianceSource attributetransparency (HTI-1)Institutionalscaling decisionMulti-siterolloutChange managementprogramPatient communication& consentReal-world performancemonitoringSite-specificperformance trackingData driftdetectionConcept driftdetectionInput data qualitymonitoringBias monitoring &health equity tracking📌 MedWatch MDRreporting (devices)Voluntary adverse eventreporting (non-device)User feedback &complaint trackingAutomated performancedashboardsModel retrainingtrigger assessmentPCCP-governedmodificationNew submissionrequired?Updated labeling& Model CardPost-marketsurveillance studiesSite-specific revalidationafter updatesCybersecurity patchmanagementAnnual performancereportingDe-implementation &retirement decisionAlgorithmvigilanceprogramCPT / HCPCS codeidentificationAMA CPT applicationprocessRadiology AI CPT codes(e.g., 0689T-0694T)Payer evidencerequirementsCMS coveragedecision pathwayCommercial payerpolicy developmentValue-based &outcomes contractingHealth economic outcomesresearch (HEOR)Guideline & societyrecommendationClinical adoption &trust dynamicsAutomation biasmanagementPatient engagementstrategyEvidence generation(real-world deployment)Publication &dissemination strategyCompetitive landscape& market analysisGenerative AI &foundation modelsFederated learning &privacy-preserving AIEU AI Act complianceassessmentState AI legislation(CO, CA, etc.)Liability & malpracticeframework evolution🏁 URAC Health Care AIAccreditation (2 tracks)🏁 CTA ANSI/CTA-2135Predictive Health AI Std🏁 Joint Commission AIGuidance (cert planned 2026)AHA AI AssessmentProgram (cardio)🏁 NIST AI RMF 1.0alignmentISO/IEC 42001 AImanagement systemIEEE clinicalAI standards🏁 New problemidentification LEGEND Activity Milestone / Deliverable Decision Point Optional / Conditional Recent Regulatory Change (2024-2026) Image/Signal AI: Always Device Pathway 🏁 Milestone (deliverable) 📌 FDA-required — cannot be skipped Primary flow Feedback loop Governance / conditional Sources: FDA TPLC (2025 draft), FDA CDS (2026), PCCP (Aug 2025), GMLP, NIST AI RMF 1.0, NAM, Duke, ONC HTI-1, URAC, JC, CTA-2135 DISCLAIMER: Reference visualization for educational purposes only. Not legal, regulatory, or medical advice. Consult qualified professionals. Modeled on NCATS 4D Maps (ncats.nih.gov). CC BY-SA 4.0